APRI Research and Charts

APRI - Apricus Biosciences Inc (Healthcare: Drug Manufacturers - Specialty & Generic)

Projected Earnings Date: 2018-08-13 (Delayed quote data 2025-03-27)

Last 0.00	Change ⇓ 0.00 (0.00%)	Volume 2
	Open 0.00	High 0.00	Low 0.00

8EMA (Daily) 0.00	40EMA (Daily) 0.04	50EMA (Daily) 0.07	STO (Daily) 0.000	MACD Hist (Daily) 0.011
8EMA (Weekly) 0.028	40EMA (Weekly) 0.44	50EMA (Weekly) 0.50	STO (Weekly) 0.000	MACD Hist (Weekly) 0.002


Company Profile
Apricus Biosciences Inc is a pharmaceutical company. It focuses on the development of product candidates in the areas of urology and rheumatology. The company has two product candidates currently in development invluding Vitaros and RayVa.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.